ID   PCL12
AC   CVCL_2H32
SY   PCL-12
DR   DSMZ; ACC-794
DR   DSMZCellDive; ACC-794
DR   Wikidata; Q38098382
RX   PubMed=26110819;
RX   PubMed=26222697;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-794).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-794
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 20,23
ST   Penta D: 8,9
ST   Penta E: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
RX   PubMed=26110819; DOI=10.1371/journal.pone.0130195; PMCID=PMC4481539;
RA   Agathangelidis A., Scarfo L., Barbaglio F., Apollonio B.,
RA   Bertilaccio M.T.S., Ranghetti P., Ponzoni M., Leone G., De Pascali V.,
RA   Pecciarini L., Ghia P., Caligaris-Cappio F., Scielzo C.;
RT   "Establishment and characterization of PCL12, a novel CD5+ chronic
RT   lymphocytic leukaemia cell line.";
RL   PLoS ONE 10:e0130195.1-e0130195.17(2015).
//
RX   PubMed=26222697; DOI=10.1371/journal.pone.0134748; PMCID=PMC4519319;
RA   Agathangelidis A., Scarfo L., Barbaglio F., Apollonio B.,
RA   Bertilaccio M.T.S., Ranghetti P., Ponzoni M., Leone G., De Pascali V.,
RA   Pecciarini L., Ghia P., Caligaris-Cappio F., Scielzo C.;
RT   "Correction: Establishment and characterization of PCL12, a novel CD5+
RT   chronic lymphocytic leukaemia cell line.";
RL   PLoS ONE 10:e0134748.1-e0134748.2(2015).
//